Associations of Phosphorus Concentrations with Medial Arterial Calcification in Lower-extremity Arteries and Diabetic Foot in People with Diabetes: a Retrospective Cross-sectional Study

Overview

Journal Cardiovasc Diabetol

Publisher Biomed Central

Specialties Cardiology & Vascular Diseases
Endocrinology

Date 2024 Jul 26

PMID 39061014

Authors

Peishan Li

Qingxian Li

Mingyu Tang

Xingyun Hu

Jing Tian

Jianbin Zhang

Chuan Yang

Baile Zhu

Affiliations

Soon will be listed here.

Abstract

Background: The aim of this study was to investigate the associations of blood phosphorus levels with the risk of developing medial arterial calcification (MAC) in lower-limb arteries and diabetic foot (DF) in diabetes patients. We sought to enhance the understanding of the pathophysiology of diabetic complications and develop strategies to mitigate diabetes-related risks.

Methods: We conducted a retrospective analysis of 701 diabetic patients from the Department of Endocrinology at Sun Yat-Sen Memorial Hospital (2019-2023). We utilized multimodel-adjusted logistic regression to investigate the associations of serum phosphorus levels and the risk of developing MAC and DF. Restricted cubic spline plots were employed to model the relationships, and threshold analysis was used to identify inflection points. Subgroup analyses were performed to explore variations across different demographics. The diagnostic utility of phosphorus concentrations was assessed via the C index, net reclassification improvement (NRI), and integrated discrimination improvement (IDI).

Results: Of the 701 patients (mean age 63.9 years; 401 (57.20%) were male), 333 (47.50%) had MAC, and 329 (46.93%) had DF. After controlling for numerous confounding variables, each one-unit increase in phosphorus concentrations was associated with an increased risk of developing MAC (OR 2.65, 95% CI 1.97-3.57, p < 0.001) and DF (OR 1.54, 95% CI 1.09-2.18, p = 0.014). Phosphorus levels demonstrated a linear risk association, with risk not being uniform on either side of the inflection point, which was approximately 3.28 mg/dL for MAC and varied for DF (3.26 to 3.81 mg/dL). Adding the phosphorus as an independent component to the diagnostic model for MAC and DF increased the C index, NRI, and IDI to varying degrees.

Conclusions: Elevated serum phosphorus levels are significantly associated with an increased risk of developing MAC and DF among diabetic people. These findings suggest that phosphorus management could be integrated into routine diagnostic processes to improve the identification and management of lower-extremity diabetic complications.

References

Lachman A, Spray T, KERWIN D, SHUGOLL G, Roberts W . Medial calcinosis of Mönckeberg. A review of the problem and a description of a patient with involvement of peripheral, visceral and coronary arteries. Am J Med. 1977; 63(4):615-22. DOI: 10.1016/0002-9343(77)90207-8. View

Guzman R, Bian A, Shintani A, Stein C . Association of foot ulcer with tibial artery calcification is independent of peripheral occlusive disease in type 2 diabetes. Diabetes Res Clin Pract. 2013; 99(3):281-6. PMC: 3628094. DOI: 10.1016/j.diabres.2012.12.022. View

Zettervall S, Soden P, Ultee K, Seldon C, Oh J, McGann K . Elevated serum phosphate levels are associated with decreased amputation-free survival after interventions for critical limb ischemia. J Vasc Surg. 2016; 65(2):431-437. PMC: 5272835. DOI: 10.1016/j.jvs.2016.06.097. View

Edmonds M . Medial arterial calcification and diabetes mellitus. Z Kardiol. 2000; 89 Suppl 2:101-4. DOI: 10.1007/s003920070107. View

Goodman W, Goldin J, Kuizon B, Yoon C, Gales B, Sider D . Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000; 342(20):1478-83. DOI: 10.1056/NEJM200005183422003. View

Gabir M, Hanson R, Dabelea D, Imperatore G, Roumain J, BENNETT P . The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care. 2000; 23(8):1108-12. DOI: 10.2337/diacare.23.8.1108. View

Kim M, Ahn C, Kang S, Nam J, Kim K, Park J . Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults. Cardiovasc Diabetol. 2017; 16(1):108. PMC: 5568209. DOI: 10.1186/s12933-017-0589-4. View

Foley R, Collins A, Herzog C, Ishani A, Kalra P . Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol. 2008; 20(2):397-404. PMC: 2637043. DOI: 10.1681/ASN.2008020141. View

Liu K, Chu W, Kong A, Ko G, Ma R, Chan J . US assessment of medial arterial calcification: a sensitive marker of diabetes-related microvascular and macrovascular complications. Radiology. 2012; 265(1):294-302. DOI: 10.1148/radiol.12112440. View

10.

Block G, Raggi P, Bellasi A, Kooienga L, Spiegel D . Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int. 2007; 71(5):438-41. DOI: 10.1038/sj.ki.5002059. View

11.

Hinchliffe R, Forsythe R, Apelqvist J, Boyko E, Fitridge R, Hong J . Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020; 36 Suppl 1:e3276. DOI: 10.1002/dmrr.3276. View

12.

Vlacho B, Bundo M, Llussa J, Real J, Mata-Cases M, Cos X . Diabetic foot disease carries an intrinsic high risk of mortality and other severe outcomes in type 2 diabetes: a propensity score-matched retrospective population-based study. Cardiovasc Diabetol. 2024; 23(1):209. PMC: 11188162. DOI: 10.1186/s12933-024-02303-1. View

13.

Osuka S, Razzaque M . Can features of phosphate toxicity appear in normophosphatemia?. J Bone Miner Metab. 2012; 30(1):10-8. PMC: 3804315. DOI: 10.1007/s00774-011-0343-z. View

14.

Bai W, Li J, Liu J . Serum phosphorus, cardiovascular and all-cause mortality in the general population: A meta-analysis. Clin Chim Acta. 2016; 461:76-82. DOI: 10.1016/j.cca.2016.07.020. View

15.

Razavi A, Cardoso R, Dzaye O, Budoff M, Thanassoulis G, Post W . Risk Markers for Limited Coronary Artery Calcium in Persons With Significant Aortic Valve Calcium (From the Multi-ethnic Study of Atherosclerosis). Am J Cardiol. 2021; 156:58-64. PMC: 8429123. DOI: 10.1016/j.amjcard.2021.06.035. View

16.

Goluke N, Schoffelmeer M, de Jonghe A, Emmelot-Vonk M, de Jong P, Koek H . Serum biomarkers for arterial calcification in humans: A systematic review. Bone Rep. 2022; 17:101599. PMC: 9234354. DOI: 10.1016/j.bonr.2022.101599. View

17.

Losurdo F, Ferraresi R, Ucci A, Zanetti A, Clerici G, Zambon A . Association of infrapopliteal medial arterial calcification with lower-limb amputations in high-risk patients: A systematic review and meta-analysis. Vasc Med. 2020; 26(2):164-173. DOI: 10.1177/1358863X20979738. View

18.

So J, Park J, Kim J, Park I, Ha E, Chung S . Medial Arterial Calcification and the Risk of Amputation of Diabetic Foot Ulcer in Patients With Diabetic Kidney Disease. J Korean Med Sci. 2023; 38(21):e160. PMC: 10226849. DOI: 10.3346/jkms.2023.38.e160. View

19.

Kendrick J, Chonchol M . The role of phosphorus in the development and progression of vascular calcification. Am J Kidney Dis. 2011; 58(5):826-34. PMC: 3199354. DOI: 10.1053/j.ajkd.2011.07.020. View

20.

Adeney K, Siscovick D, Ix J, Seliger S, Shlipak M, Jenny N . Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol. 2008; 20(2):381-7. PMC: 2637048. DOI: 10.1681/ASN.2008040349. View